Home/Filings/4/0001209191-23-048162
4//SEC Filing

Mason Michael 4

Accession 0001209191-23-048162

CIK 0001503802other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:30 PM ET

Size

5.0 KB

Accession

0001209191-23-048162

Insider Transaction Report

Form 4
Period: 2023-09-01
Mason Michael
SVP, CFO & Treasurer
Transactions
  • Sale

    Common Stock

    2023-09-01$1.33/sh6,913$9,203237,817 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.

Issuer

Karyopharm Therapeutics Inc.

CIK 0001503802

Entity typeother

Related Parties

1
  • filerCIK 0001514291

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:30 PM ET
Size
5.0 KB